Where Can You Sell Peptides? What Each Platform Policy Actually Says

The platform question resolves into a different question

Can you sell peptides on Shopify, on Facebook, on Amazon, on TikTok Shop? The question gets asked as though each platform has a peptide policy you could look up and comply with. Most of them do not, and the one answer that matters is usually written by somebody else entirely.

There are two different systems here that get discussed as one. A storefront platform sells you software and delegates the product question to whoever processes your payments. A marketplace sells access to its own buyers and applies its own product bans on top of everything else. Those are not the same decision, and confusing them is how operators end up building on a permission that was never theirs.

This article separates them, quotes what each published document actually says, and names the two platforms where the answer could not be sourced.

Shopify does not have a peptide policy, and says so

The Shopify Payments terms of service contain a section headed Prohibited and Restricted Businesses. It states that certain categories are prohibited from using the Payments Services or require additional review, and then it delegates: "The types of business categories and business practices that are considered Prohibited Businesses or Restricted Businesses are provided by each Payment Processor in your Designated Country and can be located at the links found in the Payment Processor List. These lists are meant to be representative but not exhaustive."

Read that carefully, because it answers the question that gets asked and it does so by redirecting it. Shopify is not the authority on whether your catalog is acceptable. The payment processor behind Shopify Payments in your country is, and Shopify tells you to go read that processor's list.

In the United States that processor is Stripe, whose restricted businesses list names nutraceuticals and pseudo-pharmaceuticals among restricted categories, specifically identifying pseudo-pharmaceuticals or nutraceuticals that are not safe or make harmful claims, and separately names incorrectly labeled research chemicals.

So the answer to whether you can sell peptides on Shopify is not found on Shopify. It is found on Stripe, and it attaches to claims and labeling rather than to the substance.

WooCommerce proves the same point by having no policy at all

WooCommerce is self-hosted software. There is no marketplace, no listing review, and no product policy, because there is no intermediary between you and your buyer other than the one you choose.

That makes the processor the entire policy layer. Whatever gateway you install, its acceptable use terms are the whole of the product restriction that applies to you. PayPal's acceptable use policy, for instance, prohibits transactions involving certain categories of regulated substance.

Operators often read a self-hosted platform as freedom from policy. It is the opposite of a policy vacuum. It is a configuration in which one document governs completely and you selected it.

Note on sourcing: the WooPayments prohibited-businesses page could not be retrieved during this research. Three published locations returned a 404 in a rendered browser session, so no WooPayments-specific provision is quoted here. Read the current terms of whichever gateway you actually install.

Marketplaces apply their own bans, and the category language is broad

A marketplace is a different arrangement. You are selling to its buyers under its rules, and its product bans apply regardless of what your processor permits.

Meta. The commerce policies contain two provisions that reach this category. Under Prescription Products, Drugs, and Drug Paraphernalia: "Commerce content may not promote the buying, selling, or trading of drugs, drug paraphernalia or prescription products." Under Medical and Healthcare Products: "Commerce content may not promote the buying, selling, or trading of medical and healthcare products and services, including medical devices or ingestible supplements."

The second provision is the wider one, and it is easy to miss while reading for the word drug. It is a prohibition on a category defined by function rather than by legal status.

eBay. The drugs and drug paraphernalia policy states that "Illegal drugs, drug paraphernalia, and drug-like substances are not allowed", and separately that "Prescription drugs, or products containing prescription-strength medication, are not allowed", while "Over-the-counter medications, herbal products, vitamins and veterinary medicines must follow guidelines for listing".

The operative phrase is drug-like substances. It is broader than drugs, it is not defined by approval status, and it is the category language that reaches material sitting between the defined lanes.

The same policy set also prohibits "Needles, with or without a disposable syringe", and prohibits "Items or devices that could be abused to facilitate the manufacture of illegal drugs or pharmaceutical products".

Amazon. The restricted products overview states that "The sale of illegal, unsafe, or other restricted products listed on these pages, including products available only by prescription, is strictly prohibited", and lists both Drugs and drug paraphernalia and Dietary supplements among the restricted categories requiring review.

Note on sourcing: the individual Amazon drugs sub-page and the TikTok Shop prohibited products policy could not be retrieved in a rendered browser session across three candidate locations each. Nothing platform-specific is quoted for TikTok Shop here, and the Amazon material above is quoted from the restricted products overview rather than the sub-page.

The adjacent-supplies rule that spans both systems

One prohibition appears in the platform rules and in the enforcement record at the same time, which makes it worth isolating.

eBay's policy prohibits needles with or without a disposable syringe. That is a platform rule about an accessory, not about a compound. It matters beyond eBay because the same logic operates in the intended-use analysis: under 21 CFR 201.128, intended use is determined by the objective intent of the seller, read from labeling, advertising, and the circumstances of the sale, and what you sell alongside a product is one of those circumstances.

An operator reading platform policies compound by compound will not find this, because it is not about the compound. The question a catalog review has to ask is not only whether each item is permitted, but what the combination of items represents about intended use.

eBay's medical device policy makes the same move in a different direction, and it is worth reading alongside. It states that any medical device requiring a prescription cannot be sold, and separately prohibits "Items or devices that could be abused to facilitate the manufacture of illegal drugs or pharmaceutical products". That second clause is not scoped to a product category at all. It is scoped to a capability, meaning the assessment is about what the item enables rather than what the item is.

Both clauses point at the same underlying question, which is the one a catalog review should be built around. Platform policies and the intended-use analysis are not two separate compliance workstreams that happen to overlap. They are two readers asking what your storefront represents, one of whom can remove your listings and one of whom can reclassify your product.

What this means operationally

Three consequences follow, and they are decidable before you build.

Identify your actual authority before reading any platform's marketing pages. On a storefront platform it is your processor's restricted business list, because the platform's own terms say so. On a marketplace it is the marketplace policy and the processor policy together, and the stricter one governs.

Read the category language, not the compound names. None of the documents quoted above uses the word peptide. They use drug-like substances, ingestible supplements, pseudo-pharmaceuticals, incorrectly labeled research chemicals, and products available only by prescription. A catalog is evaluated against those categories, and a search for your compound name will return nothing while the prohibition still applies.

Regard marketplace access and processing as two permissions, not one. They can be withdrawn independently, they are reviewed by different parties on different triggers, and holding one has never implied the other.

Re-read the documents on a schedule, because several of them say they are incomplete. Shopify's terms state that the processor lists "are meant to be representative but not exhaustive", and Amazon's overview notes that the examples it provides are not all-inclusive. A policy document that describes itself as representative is telling you that compliance with its literal text is the floor rather than the ceiling, and that the category, not the enumerated example, is what governs.

The practical version of that is a calendar entry rather than a principle. The documents change without notice and the review that matters to you happens on the platform's schedule, so the only way to notice a change before it costs you something is to look on your own schedule instead of waiting to be told.

The position, stated plainly

Our view, offered as judgment rather than as a finding: asking which platform allows peptides is the wrong question, and asking it is usually a sign that a business is about to be built on somebody else's permission without noticing.

The question feels practical. It sounds like due diligence. What it actually does is regard a revocable permission as though it were a property right. Shopify does not owe you an account. Meta does not owe you a commerce surface. A processor can withdraw underwriting on a review you never see, and none of those parties has made you any promise beyond terms they reserve the right to change and describe, in their own words, as representative rather than exhaustive.

The better question is the uncomfortable one. What does your business look like on the day the largest of these permissions is withdrawn? An operator who can answer that has built something. An operator who cannot has built a storefront on a lease they have never read, with a landlord who is not obliged to give notice.

We would go one step further, and this is where the argument turns from caution to opportunity. The single most valuable asset in this category is the one none of these platforms controls, which is a direct relationship with your customers and a way to reach them that does not route through a company that can decline to carry you.

That asset is unusually cheap to build here, and the reason is the same difficulty everyone complains about. In a category where the obvious paid channels are restricted, every competitor is under the same constraint, so nobody is out-bidding you for attention on the channels that remain. Owned distribution is expensive to build in a market where advertising works, because advertising is faster. In this market advertising is fenced, which means the slow asset is also the competitive one, and the operators who start building it now are compounding something their competitors are structurally discouraged from copying.

The strongest argument against this

The fair objection is that this is easy to say and expensive to act on. Building independent distribution is slow, marketplaces and paid social are where the buyers already are, and an operator who refuses to use a channel because it might be withdrawn will lose to one who uses it and grows faster. Optimizing for a risk that may never arrive is its own kind of failure, and plenty of businesses have died of caution while worrying about a landlord who never actually called.

That is correct, and we are not arguing for abstinence. Use the channels. They work, and refusing them on principle is a strategy for staying small.

Our disagreement is with the accounting rather than the choice. Growth bought on a revocable permission is real growth and it is also a borrowed position, and the mistake is not using the channel but recording the borrowed part as if it were owned. The practical form of this is not dramatic: it is knowing which share of revenue depends on a permission you do not control, and deliberately converting some of that share into a relationship you do. That is a portfolio decision made with open eyes, and it is fully compatible with using every channel available to you today.

What this does not cover

This describes published platform and processor policies as retrieved on 7 August 2026 and quotes them directly. It is not legal advice, and none of these documents determines the legal status of any product.

Platform policies change without notice, and several of the documents quoted state that their lists are representative rather than exhaustive. Two sources could not be retrieved despite rendered browser attempts across multiple published locations, and they are named above rather than filled in from secondary commentary. Advertising policies are a separate body of rules from commerce and listing policies, and are not covered here. Non-United States policy variants are not covered.

Frequently asked questions

Can I sell peptides on Shopify?

Shopify's Payments terms delegate the question, stating that prohibited and restricted business categories are provided by each payment processor in your designated country. In the United States that means the Stripe restricted businesses list, which names nutraceuticals, pseudo-pharmaceuticals, and incorrectly labeled research chemicals.

Can I sell peptides on Facebook or Instagram?

Meta's commerce policies prohibit commerce content promoting the buying, selling, or trading of drugs, drug paraphernalia, or prescription products, and separately prohibit medical and healthcare products and services including medical devices or ingestible supplements. The second provision is the wider of the two and is easy to miss when reading for the word drug, because it describes a category by what the product does rather than by its legal or approval status.

Can I sell peptides on eBay?

eBay's policy states that illegal drugs, drug paraphernalia, and drug-like substances are not allowed, and prohibits prescription drugs and products containing prescription-strength medication. The phrase drug-like substances is broader than approval status.

Can I sell peptides on Amazon?

Amazon's restricted products overview states that the sale of restricted products, including products available only by prescription, is strictly prohibited, and lists drugs and drug paraphernalia and dietary supplements among restricted categories requiring review.

Does WooCommerce have fewer restrictions?

WooCommerce is self-hosted software with no marketplace policy, which means the payment gateway you install supplies the entire product restriction that applies to you. That is one governing document rather than none.

Why does none of these policies mention peptides?

Because they are written by category rather than by compound. Drug-like substances, ingestible supplements, pseudo-pharmaceuticals, and products available only by prescription are the operative terms, and a catalog is assessed against those.

Where this fits

The processing relationship these policies feed into is covered in high-risk payment processing for peptide ecommerce, the intended-use mechanism behind the adjacent-supplies rule is in research use only, what it actually means, and the licensing layer that sits underneath all of it is in do you need a license to sell peptides.

All compounds referenced anywhere on this site are supplied strictly for laboratory research purposes only. Nothing here is for human consumption, and nothing here is intended to diagnose, treat, cure, or prevent any disease.